Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

Rituximab in the Treatment of Patients With Bullous Pemphigoid

NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (EgE)-Mediated Food Allergy Previously Treated With Linvoseltamab

NCT06631677 ·Status: TEMPORARILY_NOT_AVAILABLE

Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid

NCT07210554 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

NCT02704429 ·Status: COMPLETED ·Phase: PHASE2

The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

NCT06012448 ·Status: COMPLETED ·Phase: PHASE4

Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy

NCT04173442 ·Status: COMPLETED

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)

NCT05061771 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid

NCT04128176 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of LY3041658 in Adults With Hidradenitis Suppurativa

NCT04493502 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

NCT05681481 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

NCT02226146 ·Status: COMPLETED ·Phase: PHASE2

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

NCT07287644 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

NCT06915766 ·Status: AVAILABLE

A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

NCT07316114 ·Status: RECRUITING

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

NCT03055195 ·Status: TERMINATED ·Phase: PHASE2

Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody

NCT04563923 ·Status: COMPLETED ·Phase: PHASE2

Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

NCT01571895 ·Status: TERMINATED ·Phase: PHASE2

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

NCT04180488 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

NCT01920477 ·Status: TERMINATED ·Phase: PHASE3

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

NCT00072592 ·Status: COMPLETED ·Phase: PHASE1

Ixekizumab in the Treatment of Bullous Pemphigoid

NCT03099538 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

NCT04762277 ·Status: COMPLETED ·Phase: PHASE2

Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

NCT00483119 ·Status: TERMINATED ·Phase: PHASE2

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

NCT05192200 ·Status: COMPLETED ·Phase: PHASE2